eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | atrial fibrillation |
| Comorbidity | C0035439|rheumatic heart disease |
| Sentences | 10 |
| PubMedID- 24282904 | Expression of nfkappab, icam1, and vcam1 in rheumatic heart disease with atrial fibrillation. |
| PubMedID- 22977751 | Several recommendations have been made for the perioperative management of anticoagulation in patients at risk for arterial thromboembolism who are undergoing surgery.23 the approach in high-risk patients on warfarin and with atrial fibrillation (e.g., associated with prior thromboembolism, rheumatic heart disease, left ventricular dysfunction) or those with older-generation mechanical heart valves, in whom there is a fragile balance between the risk of bleeding and the risk of thromboembolism, is to administer intravenous heparin until 6 hours before the procedure and to restart heparin as soon as possible after surgery. |
| PubMedID- 25766663 | Early efficacy analysis of biatrial ablation versus left and simplified right atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease. |
| PubMedID- 21911268 | The increase in sympathetic nerve density in the atrium facilitates atrial fibrillation in patients with rheumatic heart disease. |
| PubMedID- 25742550 | The midterm results of radiofrequency ablation and vagal denervation in the surgical treatment of long-standing atrial fibrillation associated with rheumatic heart disease. |
| PubMedID- 25216788 | Introduction: there are few studies comparing the pathology of the remodeled substrate in patients of rheumatic heart disease with atrial fibrillation (af) and normal sinus rhythm (nsr). |
| PubMedID- 25971370 | To investigate the involvement of transforming growth factor-beta1 (tgf-beta1) and tissue inhibitor of metalloproteinase 4 (timp-4) in influencing the severity of atrial fibrosis in rheumatic heart disease (rhd) patients with atrial fibrillation (af). |
| PubMedID- 20417758 | Efficacy of surgical ablation of atrial fibrillation in patients with rheumatic heart disease. |
| PubMedID- 22676979 | Conclusions: concomitant bipolar radiofrequency ablation is an effective and safe technique for treating atrial fibrillation in patients with rheumatic heart disease undergoing valve replacement, with promising follow-up results. |
| PubMedID- 25151145 | Angiotensin ii activates signal transducers and activators of transcription 3 via rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease. |
Page: 1